Navigation Links
Blood Flow to Kidneys Better Restored by Less Invasive Procedures

A study published in the Journal of Vascular Surgery reported that minimally invasive procedures such as stenting and angioplasty proved better// when accompanied by a suction device to remove the blocking material from the blood vessels that supply kidneys.

Researchers from the Wake Forest University Baptist Medical Center have concluded from a pilot study that short, less invasive procedures restored enough blood flow to the kidneys.

‘Three to six weeks after the minimally invasive procedure, kidney function was roughly equal to what is typically achieved with major surgery,’ said Matthew S. Edwards, M.D., M.S., assistant professor of surgery and lead author. ‘We hope this will lead to a better way to do angioplasty and stenting by preventing damage to the kidneys and improving kidney function.’

The study suggests that the key to success was using suction to prevent the plaque and other material that make up blockages from reaching the kidneys and causing damage. In previous studies of angioplasty without a suction or filtering device, results have been inconsistent.

Angioplasty involves inserting a balloon-like device into the vessel to crush fatty deposits that are blocking blood flow. In many cases, a stent, or scaffold-like device, is inserted to help keep the vessel open. In this study, Edwards used what is called a ‘distal embolic protection system’ that consisted of a balloon system to temporarily block the vessel and a suction system to remove the bits of crushed material that made up the blockage. (Undesirable particles and air bubbles in the blood are known generally as ‘emboli.’)

The study involved 32 patients with a mean age of 70 years. Kidney function improved in 50 percent of the procedures and worsened in none. The narrowed arteries were reopened in 100 percent of cases and mean blood pressure was reduced from 176/81 mm Hg to 158/76 mm Hg.

‘These data suggest that distal embolic protection
'"/>




Page: 1 2

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time

Post Your Comments:
(Date:11/25/2009)...ire/--WhenmostpeopleheartheacronymTMJ,theythinkoft...helptheyneed.TMJstandsfortheTemporal-MandibularJoi...ithyourskull(temporalbone). ,, Themostcommonsym...g,clickingorpoppingofthejaw.Butmanyothersymptomsca...igue,sleepdisturbances,irritability,alossinfocus,r...
(Date:11/25/2009)...MedicalInc.,aleadingmanufacturerofbreastMRIcoilsan...eadingedgeclinicalapplicationsonitsAegis(TM)medica...cietyofNorthAmerica(RSNA)annualmeetinginChicago,No...veragetheuniquehighqualityimagesgeneratedbySentine...magingmodalitiesformulti-parametricassessment. ,...
(Date:11/25/2009)...ayAreaAirQualityManagementDistrictisissuingtheseas... forThursday,November26,2009whichbansburningwood,m...andoutdoors. ,, "Cold,stillweatherwillcontribut...executiveofficeroftheAirDistrict."We,reaskingBayAr...llowcommunitymembersthisThanksgiving,andnottoburnw...
(Date:11/25/2009)... collaboration between UCLA engineers and physicia...illion Americans who suffer from peripheral arteri... arteries, peripheral arterial disease, or PAD, is...teries reduce blood flow to the limbs. The conditi...heart attack and stroke, and its progression can r...
(Date:11/25/2009)...tment clinics to resume Monday, Nov. 30 , ...09 -- Centegra Health System is continuing to offe...ur Centegra Primary Care (CPC) vaccination clinics...e clinics are at CPC sites in Huntley, Woodstock, ...ws: ,   From 4:30 to 7:30 p.m. Tuesday...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ts , , FRIDAY, Nov. 21 (HealthDay News) -...at child,s risk of asthma, new research suggests. ...e the peak of winter virus season -- have almost a...Journal of Respiratory and Critical Care Medicine ...
... are not given adequate drug therapy. This is the ...dition of Deutsches rzteblatt International ( Dt...r et al. present the German results of this prospe...cardiovascular diseases and 10.8% only exhibited r...
...oration (NYSE: HUN ) today announced that its Fo...r Americans chosen by the American Cancer Society ... honor. Given annually, the,award is reserved for...or,personally contributed over $600 million to the...
...utual Life,Insurance Company (MassMutual) today an...ng Officers. , -- Roger W. Crandall, Co-Chie...Chief Investment Officer, will assume the position...Operating Officer,and join the company,s Board of ...
...Inc.,( http://www.cardiosolutionsinc.com ) has ann... Ph.D. to the position of Chief Surgical Officer. ...er for Aortic Surgery and Director of the,Marfan S...c. is developing its proprietary Percu-Pro(TM) Sys...
...ocated in,Pittsburgh PA, and a subsidiary of Draeg...ountering what it believes are unsubstantiated all...formerly Bacou-Dalloz USA) of a patent,infringemen... property rights, but,believes that this lawsuit i...
Other Medicine News:Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3Health News:Jon M. Huntsman Receives American Cancer Society Medal of Honor 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 3Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 4Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 5Health News:Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasi...dondevelopingproductsforminimallydisruptivesurgica...taconferencecallonMonday,November30,2009,at5:30p.m...issuesrelativetoreimbursementfortheCompany,sproduc...hortquestionandanswersession.Thedial-innumbersare1...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.coma...tscatalogue: ,, IntranasalDrugDelivery-USMarke...p0164267/Intranasal-Drug-Delivery---US-Market-Tren...rymarketiswitnessinganexpansionoftherapeuticapplic...cdrugstothedeliveryofsystemictherapeuticdrugs.Thef...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Che...aldatafromtheCompany,sPROTECT-1(theProspectiveRand...fTraficet-EN(TM)(CCX282-B)inpatientswithmoderate-t...withafavorablesafetyandtolerabilityprofile.Thestud...ionofdiseaseseverityasdefinedasa70-pointdecreasein...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 1OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 2OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 3Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 1Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 2Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 1Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 2Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 3
...SynergEyes, Inc., the high Dk hybrid contact lens ... million in Series C financing to fund the develop...d contact lens products and to expand sales and ma...f Palo Alto, CA, led this round as well as SynergE...joined Series A and B investors: Alloy Ventures, D...
...e of Cardiology publishes positive ATLAS clinical ... Corporation (NYSE: BSX ) today announced that i...ration (FDA) the final modules of the Company,s Pr...TAXUS(R) Liberte(R) Atom(TM) Paclitaxel-Eluting Co... Paclitaxel-Eluting Coronary Stent System. If app...
Other Medicine Technology:SynergEyes, Inc. Raises $13.3 Million in 'Series C' Financing 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5
Basic modular VICTOR2 Multilabel Counter (3 technologies)
VICTOR2 V (5 technologies), manual model
VICTOR2 multilabel counter with stacker and robot loading
... 96-channel parallel detection of fluorescence, ab...l microtiter plates. Compact workstations and sys...ansport of microtiter plates with a throughput of ... switching required by numerous other systems to s...
Medicine Products: